Basic Information
| RNALocate ID: | RLID:01001640 |
| RNA Symbol: | hsa-miR-183-5p |
| Localization: | Nucleus |
RNA Information
| RNA Name: | hsa-miR-183 |
| RNA ID: | miRBase:MIMAT0000261 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24918059 |
| Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
| Method: | Microarray |
| Description: | Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001639 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11001441 | Exosome | Peripheral blood mononuclear cells | 19002258 |
| RLID:11001442 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001443 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11001444 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001445 | Exosome | Breast milk | 22211110 |
| RLID:11001446 | Exosome | Brain tissue | 23382797 |
| RLID:11001447 | Exosome | Plasma | 23663360 |
| RLID:11001448 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001449 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000053 | Exosome | Breast milk|Colon tissue|Epithelial cells|Lymphoma tissue|Tongue tissue | |
| RLID-D:11000322 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-183-5p | Pheochromocytoma | MNDR-E-MI-20642 |
| MNDR | hsa-miR-183-5p | Oral squamous cell carcinoma | MNDR-E-MI-20643 |
| MNDR | hsa-miR-183-5p | Large cell neuroendocrine cancer | MNDR-E-MI-20644 |
| MNDR | hsa-miR-183-5p | Medulloblastoma | MNDR-E-MI-20645 |
| MNDR | hsa-miR-183-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-20646 |
| MNDR | hsa-miR-183-5p | Ovarian clear cell carcinoma | MNDR-E-MI-20647 |
| MNDR | hsa-miR-183-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-20648 |
| MNDR | hsa-miR-183-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-20649 |
| MNDR | hsa-miR-183-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-20650 |
| MNDR | hsa-miR-183-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-20651 |
| MNDR | hsa-miR-183-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-20652 |
| MNDR | hsa-miR-183-5p | Her2-receptor positive breast cancer | MNDR-E-MI-20653 |
| MNDR | hsa-miR-183-5p | Breast cancer luminal | MNDR-E-MI-20654 |
| MNDR | hsa-miR-183-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-20655 |
| MNDR | hsa-miR-183-5p | Hearing loss central | MNDR-E-MI-20656 |
| MNDR | hsa-miR-183-5p | Sensorineural hearing loss | MNDR-E-MI-20657 |
| MNDR | hsa-miR-183-5p | Small intestine cancer | MNDR-E-MI-20658 |
| MNDR | hsa-miR-183-5p | Prostate cancer | MNDR-E-MI-20659 |
| MNDR | hsa-miR-183-5p | Gastric cancer | MNDR-E-MI-20660 |
| MNDR | hsa-miR-183-5p | Retinitis pigmentosa | MNDR-E-MI-20661 |
| MNDR | hsa-miR-183-5p | Alzheimer disease | MNDR-E-MI-20662 |
| MNDR | hsa-miR-183-5p | Intracranial aneurysm | MNDR-E-MI-20663 |
| MNDR | hsa-miR-183-5p | Bladder cancer | MNDR-E-MI-20664 |
| MNDR | hsa-miR-183-5p | Esophageal carcinoma | MNDR-E-MI-20665 |
| MNDR | hsa-miR-183-5p | Dysautonomia familial | MNDR-E-MI-20666 |
| MNDR | hsa-miR-183-5p | Head and neck cancer | MNDR-E-MI-20667 |
| MNDR | hsa-miR-183-5p | Graves disease | MNDR-E-MI-20668 |
| MNDR | hsa-miR-183-5p | Leukemia | MNDR-E-MI-20669 |
| MNDR | hsa-miR-183-5p | Ataxia telangiectasia | MNDR-E-MI-20670 |
| MNDR | hsa-miR-183-5p | Cardiovascular disease | MNDR-E-MI-20671 |
| MNDR | hsa-miR-183-5p | Lung cancer | MNDR-E-MI-20672 |
| MNDR | hsa-miR-183-5p | Endometrial cancer | MNDR-E-MI-20673 |
| MNDR | hsa-miR-183-5p | Down syndrome | MNDR-E-MI-20674 |
| MNDR | hsa-miR-183-5p | Parkinson disease | MNDR-E-MI-20675 |
| MNDR | hsa-miR-183-5p | Basal-like breast cancer | MNDR-E-MI-20676 |
| MNDR | hsa-miR-183-5p | Neuroendocrine neoplasia | MNDR-E-MI-20677 |
| MNDR | hsa-miR-183-5p | Thyroid cancer | MNDR-E-MI-20678 |
| MNDR | hsa-miR-183-5p | Pituitary neoplasms | MNDR-E-MI-20679 |
| MNDR | hsa-miR-183-5p | Pancreatic cancer | MNDR-E-MI-20680 |
| MNDR | hsa-miR-183-5p | Melanoma | MNDR-E-MI-20681 |
| MNDR | hsa-miR-183-5p | Rectum adenocarcinoma | MNDR-E-MI-20682 |
| MNDR | hsa-miR-183-5p | Nephroblastoma | MNDR-E-MI-20683 |
| MNDR | hsa-miR-183-5p | Colon cancer | MNDR-E-MI-20684 |
| MNDR | hsa-miR-183-5p | Colon adenocarcinoma | MNDR-E-MI-20685 |
| MNDR | hsa-miR-183-5p | Familial ovarian cancer | MNDR-E-MI-20686 |
| MNDR | hsa-miR-183-5p | Acromegaly | MNDR-E-MI-20687 |
| MNDR | hsa-miR-183-5p | Prostate adenocarcinoma | MNDR-E-MI-20688 |
| MNDR | hsa-miR-183-5p | Carcinoma ductal breast | MNDR-E-MI-20689 |
| MNDR | hsa-miR-183-5p | Invasive ductal carcinoma | MNDR-E-MI-20690 |
| MNDR | hsa-miR-183-5p | Glioblastoma | MNDR-E-MI-20691 |
| MNDR | hsa-miR-183-5p | Glioma | MNDR-E-MI-20692 |
| MNDR | hsa-miR-183-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-20693 |
| MNDR | hsa-miR-183-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-20694 |
| MNDR | hsa-miR-183-5p | Epilepsy temporal lobe | MNDR-E-MI-20695 |
| MNDR | hsa-miR-183-5p | Osteosarcoma | MNDR-E-MI-20696 |
| MNDR | hsa-miR-183-5p | Liposarcoma | MNDR-E-MI-20697 |
| MNDR | hsa-miR-183-5p | Breast carcinoma | MNDR-E-MI-20698 |
| MNDR | hsa-miR-183-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-20699 |
| MNDR | hsa-miR-183-5p | Uterine cancer | MNDR-E-MI-20700 |
| MNDR | hsa-miR-183-5p | Gastric adenocarcinoma | MNDR-E-MI-20701 |
| MNDR | hsa-miR-183-5p | Cervical squamous cell carcinoma | MNDR-E-MI-20702 |
| MNDR | hsa-miR-183-5p | Pituitary adenoma | MNDR-E-MI-20703 |
| MNDR | hsa-miR-183-5p | Lung squamous cell carcinoma | MNDR-E-MI-20704 |
| MNDR | hsa-miR-183-5p | Lung adenocarcinoma | MNDR-E-MI-20705 |
| MNDR | hsa-miR-183-5p | Adrenal cortical carcinoma | MNDR-E-MI-20706 |
| MNDR | hsa-miR-183-5p | Thyroid carcinoma | MNDR-E-MI-20707 |
| MNDR | hsa-miR-183-5p | Medullary thyroid cancer | MNDR-E-MI-20708 |
| MNDR | hsa-miR-183-5p | Ovarian carcinoma | MNDR-E-MI-20709 |
| MNDR | hsa-miR-183-5p | Bladder urothelial carcinoma | MNDR-E-MI-20710 |
| MNDR | hsa-miR-183-5p | Pancreatic adenocarcinoma | MNDR-E-MI-20711 |
| MNDR | hsa-miR-183-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-20712 |
| MNDR | hsa-miR-183-5p | Carcinoma renal cell | MNDR-E-MI-20713 |
| MNDR | hsa-miR-183-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-20714 |
| MNDR | hsa-miR-183-5p | Renal clear cell carcinoma | MNDR-E-MI-20715 |
| MNDR | hsa-miR-183-5p | Large cell carcinoma | MNDR-E-MI-20716 |
| MNDR | hsa-miR-183-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-20717 |
| MNDR | hsa-miR-183-5p | Cholangiocarcinoma | MNDR-E-MI-20718 |
| MNDR | hsa-miR-183-5p | Esophageal cancer | MNDR-E-MI-20719 |
| MNDR | hsa-miR-183-5p | Oncocytoma | MNDR-E-MI-20720 |
| MNDR | hsa-miR-183-5p | Lung small cell carcinoma | MNDR-E-MI-20721 |
| MNDR | hsa-miR-183-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-20722 |
| MNDR | hsa-miR-183-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-20723 |
| MNDR | hsa-miR-183-5p | Breast invasive carcinoma | MNDR-E-MI-20724 |
| MNDR | hsa-miR-183-5p | Hepatocellular carcinoma | MNDR-E-MI-20725 |
| MNDR | hsa-miR-183-5p | Familiar ovarian carcinoma | MNDR-E-MI-20726 |
| MNDR | hsa-miR-183-5p | Rheumatoid arthritis | MNDR-E-MI-20727 |
| MNDR | hsa-miR-183-5p | Retinoblastoma | MNDR-E-MI-20728 |
| MNDR | hsa-miR-183-5p | Thyroid hurthle cell carcinoma | MNDR-E-MI-20729 |
| MNDR | hsa-miR-183-5p | Hodgkin lymphoma | MNDR-E-MI-20730 |
| MNDR | hsa-miR-183-5p | Skin cutaneous melanoma | MNDR-E-MI-20731 |
| MNDR | hsa-miR-183-5p | Skin melanoma | MNDR-E-MI-20732 |
| MNDR | hsa-miR-183-5p | Acute myelogenous leukemia | MNDR-E-MI-20733 |
| MNDR | hsa-miR-183-5p | Colorectal cancer | MNDR-E-MI-20734 |
| MNDR | hsa-miR-183-5p | Nasopharynx carcinoma | MNDR-E-MI-20735 |
| MNDR | hsa-miR-183-5p | Acute lymphocytic leukemia | MNDR-E-MI-20736 |
| MNDR | hsa-miR-183-5p | Ependymoma | MNDR-E-MI-20737 |
| MNDR | hsa-miR-183-5p | Nasopharyngeal cancer | MNDR-E-MI-20738 |
| MNDR | hsa-miR-183-5p | Prostatic neoplasms | MNDR-E-MI-20739 |
| MNDR | hsa-miR-183-5p | Lung injury | MNDR-E-MI-20740 |
| MNDR | hsa-miR-183-5p | Stroke lacunar | MNDR-E-MI-20741 |
| MNDR | hsa-miR-183-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-20742 |
| MNDR | hsa-miR-183-5p | Breast cancer her3+ negative | MNDR-E-MI-20743 |
| MNDR | hsa-miR-183-5p | Duke A | MNDR-E-MI-20744 |
| MNDR | hsa-miR-183-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-20745 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AANAT | Homo sapiens | RR00021274 |
TOP